Christine Lonjou

3.0k citations

26 papers · 2.0k indexed · 1 hit paper · h-index 16

Co-authors: Andrew Collins Newton E. Morton Alain Hovnanian Nicolas Borot Maja Mockenhaupt Claudia de Toma Martin Schumacher Laure Thomas
Topics: Genetic Associations and Epidemiology (8 papers)Asthma and respiratory diseases (5 papers)Drug-Induced Adverse Reactions (3 papers)
Cited by: Pharmacology Rheumatology Toxicology
Journals: Proceedings of the National Academy of Sciences Nature Communications Nature Genetics
Partner nations: United Kingdom France Germany

In The Last Decade

Christine Lonjou

26 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

2008 460 citations Christine Lonjou, Nicolas Borot et al. Pharmacogenetics and Genomics profile →

Peers

Countries citing papers authored by Christine Lonjou

Since Specialization

Citations

This map shows the geographic impact of Christine Lonjou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Lonjou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Lonjou more than expected).

Fields of papers citing papers by Christine Lonjou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Lonjou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Lonjou. The network helps show where Christine Lonjou may publish in the future.

Co-authorship network of co-authors of Christine Lonjou

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Lonjou. A scholar is included among the top collaborators of Christine Lonjou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Lonjou. Christine Lonjou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer 2025 ·Nature Communications ·(unknown),Marvin Lerousseau,Fanny Orlhac,(unknown),(unknown),(unknown),(unknown),(unknown),Christine Lonjou,(unknown),Andreï Zinovyev,Hélène Salmon,Thomas Walter,Irène Buvat,Nicolas Girard,Emmanuel Barillot	13
2	Boosting GWAS using biological networks: A study on susceptibility to familial breast cancer 2021 ·PLoS Computational Biology ·Héctor Climente-González,Christine Lonjou,Fabienne Lesueur,(unknown),Dominique Stoppa‐Lyonnet,Nadine Andrieu,Chloé‐Agathe Azencott	6
3	Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation 2017 ·BMC Cancer ·Christine Lonjou,Francesca Damiola,Monika Moissonnier,Geoffroy Durand,Irina Malakhova,Vladimir Masyakin,Florence Le Calvez‐Kelm,Elisabeth Cardis,Graham Byrnes,Ausrele Kesminiene,Fabienne Lesueur	16
4	EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension 2013 ·Nature Genetics ·Mélanie Eyries,David Montani,Barbara Girerd,Claire Perret,Anne Leroy,Christine Lonjou,Nadjim Chelghoum,Florence Coulet,Damien Bonnet,Peter Dorfmüller,Élie Fadel,Olivier Sitbon,Gérald Simonneau,David‐Alexandre Trégouët,Marc Humbert,Florent Soubrier	269
5	Positive selection of protective variants for type 2 diabetes from the Neolithic onward: a case study in Central Asia 2013 ·European Journal of Human Genetics ·Laure Ségurel,Frédéric Austerlitz,Bruno Toupance,Mathieu Gautier,Joanna L. Kelley,Patrick Pasquet,Christine Lonjou,Myriam Georges,Sarah Voisin,Corinne Cruaud,Arnaud Couloux,Tatyana Hegay,Almaz Aldashev,Renaud Vitalis,Évelyne Heyer	30
6	CRB1 mutations in inherited retinal dystrophies 2011 ·Human Mutation ·Kinga M. Bujakowska,Isabelle Audo,Saddek Mohand‐Saïd,Marie‐Elise Lancelot,Aline Antonio,Aurore Germain,Thierry Léveillard,Mélanie Letexier,Jean‐Paul Saraiva,Christine Lonjou,Wassila Carpentier,José‐Alain Sahel,Shomi S. Bhattacharya,Christina Zeitz	149
7	A European study of HLA-B in Stevens–Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugsbreakdown → 2008 ·Pharmacogenetics and Genomics ·Christine Lonjou,Nicolas Borot,Peggy Sekula,(unknown),Laure Thomas,Sima Halevy,Luigi Naldi,(unknown),Alexis Sidoroff,Claudia de Toma,Martin Schumacher,Jean‐Claude Roujeau,Alain Hovnanian,Maja Mockenhaupt	460
8	HLA-DRB1 * 01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz 2008 ·AIDS ·Zulma G. Vitezica,B. Milpied,Christine Lonjou,Nicolas Borot,(unknown),(unknown),Alain Hovnanian	99
9	A marker for Stevens-Johnson syndrome …: ethnicity matters 2006 ·The Pharmacogenomics Journal ·Christine Lonjou,Laure Thomas,Nicolas Borot,(unknown),Claudia de Toma,Hervé Le-Louët,Elisabeth Graf,Martin Schumacher,Alain Hovnanian,Maja Mockenhaupt,J Roujeau,(unknown)	294
10	Linkage disequilibrium in human populations 2003 ·Proceedings of the National Academy of Sciences ·Christine Lonjou,Weihua Zhang,Andrew Collins,William Tapper,(unknown),Nikolas Maniatis,Newton E. Morton	61
11	Linkage analysis of the 5q31–33 candidate region for asthma in 240 UK families 2001 ·Genes and Immunity ·John W. Holloway,Christine Lonjou,Bianca Beghé,Qianqian Peng,Tom R. Gaunt,(unknown),Ian P. Hall,(unknown),Jennifer Wilkinson,(unknown),ST Holgate,N.E. Morton	19
12	A retrospective collaboration on chromosome 5 by the International Consortium on Asthma Genetics (COAG) 2001 ·Clinical & Experimental Allergy ·Lyle J. Palmer,Christine Lonjou,Kathleen C. Barnes,(unknown),William Cookson,Klaus A. Deichmann,John W. Holloway,Tarja Laitinen,M Wjst,Newton E. Morton	7
13	Linkage Analysis of Markers on Chromosome 11q13 with Asthma and Atopy in a United Kingdom Population 2000 ·American Journal of Respiratory and Critical Care Medicine ·N. Simon Thomas,Jane Wilkinson,Christine Lonjou,(unknown),Stephen T. Holgate	15
14	A first trial of retrospective collaboration for positional cloning in complex inheritance: Assay of the cytokine region on chromosome 5 by the Consortium on Asthma Genetics (COAG) 2000 ·Proceedings of the National Academy of Sciences ·Christine Lonjou,Kathleen C. Barnes,(unknown),W. O. C. M. Cookson,Klaus A. Deichmann,Ian P. Hall,John W. Holloway,Tarja Laitinen,Lyle J. Palmer,Matthias Wjst,Newton E. Morton	37
15	Meta-analysis and retrospective collaboration: two methods to map oligogenes for atopy and asthma. 1999 ·PubMed ·Christine Lonjou,Andrew Collins,Sarah Ennis,William Tapper,N.E. Morton	10
16	Hardy–Weinberg quality control 1999 ·Annals of Human Genetics ·(unknown),Andrew Collins,Christine Lonjou,(unknown),James Wilkinson,M. Watson,N.E. Morton	97
17	Genetic epidemiology of single-nucleotide polymorphisms 1999 ·Proceedings of the National Academy of Sciences ·Andrew Collins,Christine Lonjou,Newton E. Morton	214
18	Limb Girdle Muscular Dystrophy Type 2A (CAPN3): Mapping Using Allelic Association 1998 ·Human Heredity ·Christine Lonjou,Andrew Collins,J. Beckmann,Valérie Allamand,Newton E. Morton	6
19	HLA -A,-B,-DR HAPLOTYPE FREQUENCIES IN FRANCE—IMPLICATIONS FOR RECRUITMENT OF POTENTIAL BONE MARROW DONORS 1995 ·Transplantation ·Christine Lonjou,(unknown),Anne Cambon‐Thomsen,C Raffoux	47
20	A LIKELIHOOD APPROACH TO HLA SEROLOGY 1992 ·International Journal of Immunogenetics ·John Clayton,Christine Lonjou,(unknown),Anne Cambon‐Thomsen,E. Ohayon,J Hors,E. D. Albert	1

About Christine Lonjou

Christine Lonjou is a scholar working on Genetics, Physiology and Immunology, having authored 26 papers that have together received 2.0k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (8 papers), Asthma and respiratory diseases (5 papers) and Drug-Induced Adverse Reactions (3 papers). The work is most often cited by research in Pharmacology (718 citations), Rheumatology (398 citations) and Toxicology (77 citations). Christine Lonjou has collaborated with scholars based in United Kingdom, France and Germany. Frequent co-authors include Andrew Collins, Newton E. Morton, Alain Hovnanian, Nicolas Borot, Maja Mockenhaupt, Claudia de Toma, Martin Schumacher, Laure Thomas, Sima Halevy and Peggy Sekula. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact